Updated with comments from Carl Zeiss Meditec The FDA today granted premarket approval to Carl Zeiss Meditec (ETR:AFX) for its VisuMax femtosecond Laser, with indications for small incision lenticule extraction procedures to reduce or eliminate nearsightedness in patients 22 or older. The newly cleared laser is designed to incise the cornea to create a disc-shaped piece of tissue […]
Carl Zeiss Meditec
Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss | Personnel Moves, July 28, 2016
Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss Carl Zeiss Meditec (ETR:AFX) said this week it tapped ex-AcuFocus CEO James Mazzo as the global president of its ophthalmology business as well as managing the entire company’s U.S. sales and service center. Mazzo comes from a 3-year run as president and CEO at AcuFocus, where […]
FDA reverses stance on reporting requirement | Regulatory news for the week of October 20, 2014
Abbott inks co-distribution deal with Carl Zeiss Meditec
China fines J&J and other contact lens makers for anti-trust violations
Chinese regulators slapped a string of contact lens and eyeglass makers with more than $3 million (19 million yuan) in fines after accusing them of violating the country’s anti-trust laws.
Carl Zeiss expands lens portfolio with $70M Aaren Scientific buy
Optical lenses maker Carl Zeiss Meditec (ETR:AFX) paid $70 million to acquire 100% of the assets of intraocular lens manufacturer Aaren Scientific, the companies announced this week.
Kensey Nash recoups on Angio-Seal settlement with St. Jude | Legal Roundup
